Cargando…

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

BACKGROUND: Depressive and anxiety symptoms could seriously affect the quality of life of type 2 diabetes mellitus (T2DM) subjects. Currently, little is known about the efficacy and acceptability of agomelatine versus fluoxetine in treating these symptoms in T2DM subjects. Therefore, this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Tingting, Teng, Xiaochun, Huang, Qun, Mu, Yanfei, Tang, Xianjun, Mu, Xiaosong, Wei, Youneng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005323/ https://www.ncbi.nlm.nih.gov/pubmed/29942131 http://dx.doi.org/10.2147/NDT.S167608

Ejemplares similares

Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine
por: Liang, Zihong, et al.
Publicado: (2021)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
por: Tang, Fang, et al.
Publicado: (2016)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013)

Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action
por: Millan, Mark J.
Publicado: (2022)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018)

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
por: Pal, Sutanaya, et al.
Publicado: (2016)

Evaluation of the Highly Variable Agomelatine Pharmacokinetics in Chinese Healthy Subjects to Support Bioequivalence Study
por: Pei, Qi, et al.
Publicado: (2014)

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang, Ruiying, et al.
Publicado: (2015)

The effectiveness of pregabalin with or without agomelatine in the treatment of chronic low back pain: a double-blind, placebo-controlled, randomized clinical trial
por: Mahdavi, Seyed Mani, et al.
Publicado: (2022)

Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
por: Shokrani, Marjan, et al.
Publicado: (2023)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol(®) on glycemic control of subjects with impaired fasting glucose
por: Evans, Malkanthi, et al.
Publicado: (2015)

Subjective Assessment of Diabetes Self-Care Correlates with Perceived Glycemic Control but not with Actual Glycemic Control
por: Ohn, Jung Hun, et al.
Publicado: (2015)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression
por: Santos, Tainaê, et al.
Publicado: (2012)

Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
por: Avci, Dilek, et al.
Publicado: (2016)

The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Mostert, Jop, et al.
Publicado: (2013)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Lactobacillus plantarum HAC01 Supplementation Improves Glycemic Control in Prediabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Mi-Ra, et al.
Publicado: (2021)

Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic β-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus
por: Takai, Maiko, et al.
Publicado: (2018)

Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
por: Stein, Dan J., et al.
Publicado: (2021)

Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin
por: Harvey, Brian H, et al.
Publicado: (2019)

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus
por: Kamei, Shinji, et al.
Publicado: (2018)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
Publicado: (2019)

Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial
por: Krishnan, Karthickeyan, et al.
Publicado: (2021)

Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats
por: Lapmanee, Sarawut, et al.
Publicado: (2017)

Acute fluoxetine exposure alters crab anxiety-like behaviour, but not aggressiveness
por: Hamilton, Trevor James, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_in97diiknvuppjpolipkf0dcm9